4 Results for "

A253

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "A253" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-114245
CAS No.: 26046-90-2
Purity:  99.60%
Synonyms: Methylselenocysteine; Se-Methylseleno-L-cysteine
Se-Methylselenocysteine, a precursor of Methylselenol, has potent cancer chemopreventive activity and anti-oxidant activity. Se-Methylselenocysteine is orally bioavailable, and induces apoptosis .
loading...
    loading...
Cat. No.: HY-114245R
CAS No.: 26046-90-2
Synonyms: Methylselenocysteine (Standard); Se-Methylseleno-L-cysteine (Standard)
Risedronic acid (Standard) is the analytical standard of Risedronic acid. This product is intended for research and analytical applications. 0
loading...
    loading...
Cat. No.: HY-114245B
CAS No.: 863394-07-4
Synonyms: Methylselenocysteine hydrochloride; Se-Methylseleno-L-cysteine hydrochloride
Se-Methylselenocysteine hydrochloride, a precursor of Methylselenol, has potent cancer chemopreventive activity and anti-oxidant activity. Se-Methylselenocysteine hydrochloride is orally bioavailable, and induces apoptosis .
loading...
    loading...
Cat. No.: HY-181529
CAS No.: 1212623-02-3
Target:  

VDAC PERK

Research Areas:  

Cancer

NCATS-SM0225 is an endoplasmic reticulum-associated degradation (ERAD) inhibitor and a direct binder of VDAC1, VDAC2 and VDAC3. NCATS-SM0225 exhibits an IC50of 1.02 μM for ERAD and a Kd of 3.13 μM for human VDAC1 binding. NCATS-SM0225 disrupts cellular calcium homeostasis, enhances VDAC1-IP3R coupling and activating PERK. NCATS-SM0225 selectively kills cancer cells, exhibits tumor growth inhibitory effects in melanoma xenograft models. NCATS-SM0225 can be used for research on multiple cancers including melanoma, as well as the molecular mechanisms of ERAD and calcium homeostasis regulation .
loading...
    loading...